CYP1A1 and pulmonary arterial hypertension: Since there is evidence that CYP1A1 and transcription factor Nrf2 are protective against PAHs and ambient PM-induced pro-oxidative damage in various cell types [32, 33], we investigated their alterations in PAH-treated VSMCs.